Kubota Pharmaceutical Holdings Co., Ltd.
4596.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥2,986,941 | ¥4,447,520 | ¥5,665,645 | ¥6,784,864 |
| - Cash | ¥1,454,908 | ¥2,767,000 | ¥4,048,969 | ¥3,977,312 |
| + Debt | ¥11,040 | ¥143,206 | ¥148,000 | ¥199,000 |
| Enterprise Value | ¥1,543,073 | ¥1,823,726 | ¥1,764,676 | ¥3,006,552 |
| Revenue | ¥27,189 | ¥39,887 | ¥8,254 | ¥0 |
| % Growth | -31.8% | 383.2% | – | – |
| Gross Profit | -¥521,803 | -¥59,046 | -¥56,541 | -¥59,238 |
| % Margin | -1,919.2% | -148% | -685% | – |
| EBITDA | -¥1,223,048 | -¥1,393,068 | -¥1,945,369 | -¥2,539,045 |
| % Margin | -4,498.3% | -3,492.5% | -23,568.8% | – |
| Net Income | -¥1,332,852 | -¥1,489,602 | -¥2,015,906 | -¥2,616,451 |
| % Margin | -4,902.2% | -3,734.6% | -24,423.4% | – |
| EPS Diluted | -23.65 | -26.79 | -40.92 | -57.46 |
| % Growth | 11.7% | 34.5% | 28.8% | – |
| Operating Cash Flow | -¥1,195,075 | -¥1,335,000 | -¥2,086,695 | -¥2,513,583 |
| Capital Expenditures | -¥49,735 | -¥66,287 | -¥57,976 | -¥8,666 |
| Free Cash Flow | -¥1,244,810 | -¥1,401,000 | -¥2,144,671 | -¥2,522,249 |